1.A Randomized Controlled Clinical Study on Prevention and Treatment for Acute Radiation Esophagitis by Compound Kushen Injection
Shujun ZHAN ; Xiangdong QU ; Xia ZHANG ; Zhonghe YU
Chinese Journal of Information on Traditional Chinese Medicine 2014;(10):18-21
Objective To investigate the prevention and treatment effects of Compound Kushen Injection on acute radiation esophagitis. Methods Eighty-two eligible patients with esophageal cancer were randomly divided into the treatment group (41 cases) and the control group (41 cases). All the patients received radiotherapy. Throughout the course of radiotherapy, patients in the treatment group received Compound Kushen Injection, and patients in the control group received Kangfuxin Liquid. Occurrence time and level of radiation esophagitis, and dosage of painkillers were observed. Results Different degrees of acute esophageal toxicity were observed in the two groups. The occurrence rate of high level (degree III and degree IV) acute radiation esophagitis was 7.3%(3/41) in the treatment group, and 31.7%(13/41) in the control group. There was significant difference between the two groups (P<0.05). The dosage of the analgesic drug (Fentanyl Transdermal System) in the treatment group was far less than the controlled group (P<0.001). Conclusion Compound Kushen Injection could decrease the incidence rate of acute radiation esophagitis, and reduce the high-level esophagitis and the dosage of the analgesic drug, which can help the completion of radiation.
2.Relationship between HBV genotype and liver damage in northern China
Shujun GUO ; Juan LI ; Pei QU ; Miaomiao ZHAO ; Shujing SONG
International Journal of Laboratory Medicine 2016;37(6):763-764
Objective To discuss the relationship between hepatitis B virus (HBV) genotype and HBV DNA ,liver fibrosis ,liver function and HBeAg .Methods HBV genotypes ,HBV DNA ,liver fibrosis indicators and alanine aminotransferase(ALT ) ,aspartate aminotransferase(AST ) ,total bilirubin(TBIL) ,albumin(ALB) and HBV e antigen(HBeAg) were detected in patients with serum hepatitis .All data were statistically analyzed .Results There was no significant difference of HBV DNA ,ALT ,AST ,TBIL ,ALB , procollagen- Ⅲ -peptide ,type Ⅳ collagen ,hyaluronic acid and laminin between patients with B and C genotype infection (P> 0 .05) . However ,HBeAg level in patients with C genotype infection was higher than that in patients with B genotype infection (P< 0 .05) . Conclusion There might be no significant difference of HBV DNA ,liver function and liver fibrosis between patients with B and C genotype infection ,but HBeAg level in patients with C genotype infection could be higher than patients with B genotype infection .
3.Analysis of early dental implant failure and retreatment of 6 cases
Jianrui XIAO ; Xiaoxian HAN ; Yuxuan CHEN ; Shujun CHEN ; Liang KONG ; Hongyan QU ; Xinxin YU
Journal of Practical Stomatology 2014;(2):237-240
Objective:To analyse the causes of early implantation failure and the therapeutic measures with re-implantation after the failures.Methods:6 cases of implantation failure including early infections,loosening and non-osteointegration were reviewed and trea-ted by re-implantation therapy,and the causes of failure were discussed and the effects of re-treatment were evaluated.Results:2 cases were found to be with infection of adjacent teeth after implantation and were treated by removal of the implant,socket curettage,root ca-nal therapy(RCT)and antibiotics followed by reimplantation.Implant loosening and non-osteointegration were observed in 4 cases, which were treated by the similar methods for the implant socket.Reimplantation was successful in all 6 cases followed-up for 1 -3 years.Conclusion:Preventive measure for implantation failure should include indication selection,control of infections in adjacent teeth and periodontosis,use of GBR technic and so on.Re-implantation following proper treatment of adjacent teeth and the socket of implant is effective for the treatment of implantation failure.
4.The most appropriate way of sample collection for individualized detection of urinary iodine
Honghai LI ; Shujun QU ; Guangping LI ; Yong ZHANG ; Xiangliu OUYANG ; Wei TIAN
Chinese Journal of Endemiology 2017;36(4):246-249
Objective By studying the variation of individual urinary iodine concentration due to different ways of urine sample collection to optimize it for standard clinical evaluation.Methods Totally 20 healthy adults were recruited and their urine samples were collected as a random urine sample within 1 day,the 24 hour urine and morning urine samples within 5 successive days,respectively.The coefficient of variation in each group was calculated.Paired t test was used to compare the results of 24 hour urine with the results of random urine and that of morning urine samples,respectively.Results The range of individual coefficient of variation for random urine sample within one day was 12.5%-57.4%,while most of the coefficients of variation were around 30.39%.In contrast,the individual coefficients of variation of morning urine sample and 24 hour urine results within 5 days were 5.4%-26.0% and 3.4%-16.6% and most of them were at about 11.74% and 7.91%.The paired t test showed that the results of random urine sample were significantly different compared with that of 24 hour urine (t =-4.231,P < 0.05).On the other hand,there was also significant difference for the results of morning urine compared with that of 24 hour urine (t =3.884,P < 0.05).Conclusion This study suggests that 24 hour urine is the most appropriate way of sample collection for individualized detection of urinary iodine.
5.The characteristics of serum high-density lipoprotein cholesterol levels in urban population from Tangshan City
Bing WU ; Shujun QU ; Junhua MENG ; Lianhai CHAI ; Zhaoxia XIN ; Yuntao ZHOU ; Wei TIAN
Chinese Journal of Laboratory Medicine 2015;38(2):120-123
Objective To understand the characteristics of High-density lipoprotein cholesterol (HDL-C) distribution through analyzing serum HDL-C levels in healthy checkup subjects among local urbanese.Methods The checkup results of 36 454 cases were collected from 2009 to 2013 in Tangshan Gongren hospital (male:n =20 343,female:n =16 111).The cases with liver injury,abnormal blood glucoses,kidney injury and defined cerebrovascular diseases and metabolic disease were excluded.25 197 cases were analyzed as normal subjects including 11 114 males and 14 083 females.Kolmogorov-Smimov test,kruskal-wallis test,and Dunn multiple comparison test was performed using Bioconductor software 3.0.2 for testing normality distribution and comparing the difference of two or multiple groups,respectively.Results were analyzed statistically with R 3.0.2.Results The results showed that the average level (1.22-± 0.31) mmol/L of HDL-C among the overall population is lower than that of national average level(1.30 mmol/L).The median serum HDL-C level in female is higher than in male (1.27 and 1.08,x2 =2 606.34,P <0.01).HDL-C levels in male continuously increase from 1.06 mmol/L to 1.11 mmol/L with aging,especially in groups of over 50 years old than in groups of below 50 years old (x2 =75.19,P < 0.01).Conclusions Based on 2007 guidance on prevention and treatment by national health bureau,this study showed that there are 29.69% of the apparent healthy subjects,especially about 42.94% of the male,representing low HDL-C level under the low limit of 1.04 mmol/L.These results showed that serum HDL-C level in Tangshan urbanese is lower than that of national average level,and HDL-C level in male is tended to increase with aging.
7.Application of leucine-rich alpha-2 glycoprotein 1 in the diagnosis and treatment of digestive system tumors
Liyan SUN ; Lili XU ; Shujun QU
Chinese Journal of Primary Medicine and Pharmacy 2023;30(5):787-790
Leucine-rich alpha-2 glycoprotein 1 (LRG1) is a highly conserved member of the family of leucine-rich repeat (LRR) proteins. LRG1 has been reported to be closely related to the occurrence and development of malignant tumors. Recent studies have shown that LRG1 is abnormally expressed in many digestive system tumors, including esophageal cancer, gastric cancer, liver cancer, pancreatic cancer, and colorectal cancer. LRG1 has also been reported to be closely related to tumor cell proliferation, invasion, migration, apoptosis, and poor prognosis. This paper reviews the research progress of LRG1 in many digestive system tumors, providing new ideas for LRG1-based anti-tumor treatment.